HeartBeam Inc. (NASDAQ: BEAT) announced a strategic reorganization aimed at accelerating execution, expanding global market reach and improving capital efficiency as it advances commercialization of its cardiac monitoring technology. Under the new structure, Founder and President Branislav Vajdic, Ph.D., and Executive Chairman Rich Ferrari will lead focused implementation teams designed to streamline decision-making, improve accountability and reduce costs. As part of the transition, former CEO Robert Eno will move into a consulting role.
The company said its strategy centers on leveraging its patented 3D ECG platform across multiple healthcare channels while advancing development beyond arrhythmia assessment toward heart attack detection. HeartBeam also plans to expand partnerships with governments, health systems, ECG manufacturers and wearable device companies, building on its December 2025 FDA clearance for its synthesized 12-lead ECG technology for arrhythmia assessment.
The reorganization comes as HeartBeam seeks to capitalize on its recent regulatory milestones. The company received FDA clearance for its 3D ECG technology for arrhythmia assessment in December 2024 and for its 12-lead ECG synthesis software in December 2025. The platform is designed to collect ECG signals in 3D from three non-coplanar directions and synthesize them into a 12-lead ECG, enabling portable devices that can be used wherever the patient is. This technology aims to deliver actionable heart intelligence, allowing physicians to identify cardiac health trends and acute conditions and direct patients to appropriate care outside of medical facilities.
HeartBeam holds over 20 issued patents related to its technology enablement. The company’s strategy includes expanding partnerships with governments, health systems, ECG manufacturers and wearable device companies to broaden its market reach. The reorganization is intended to improve capital efficiency and streamline decision-making as the company moves toward commercializing its platform.
The announcement highlights the company's focus on transforming cardiac monitoring through its cable-free, 3D ECG technology. For more information, view the full press release at https://ibn.fm/CTxXi. The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT.
